A Caltech Library Service

Lessons from the pandemic: Responding to emerging zoonotic viral diseases — a Keystone Symposia report

Cable, Jennifer and Fauci, Anthony and Dowling, William E. and Günther, Stephan and Bente, Dennis A. and Yadav, Pragya Dhruv and Madoff, Lawrence C. and Wang, Lin-Fa and Arora, Rahul K. and Van Kerkhove, Maria and Chu, May C. and Jaenisch, Thomas and Epstein, Jonathan H. and Frost, Simon David William and Bausch, Daniel G. and Hensley, Lisa E. and Bergeron, Éric and Sitaras, Ioannis and Gunn, Michael D. and Geisbert, Thomas W. and Muñoz-Fontela, César and Krammer, Florian and de Wit, Emmie and Nordenfelt, Pontus and Saphire, Erica Ollmann and Gilbert, Sarah C. and Corbett, Kizzmekia S. and Branco, Luis M. and Baize, Sylvain and van Doremalen, Neeltje and Krieger, Marco A. and Costa Clemens, Sue Ann and Hesselink, Renske and Hartman, Dan (2022) Lessons from the pandemic: Responding to emerging zoonotic viral diseases — a Keystone Symposia report. Annals of the New York Academy of Sciences, 1518 (1). pp. 209-225. ISSN 0077-8923. PMCID PMC9538336. doi:10.1111/nyas.14898.

Full text is not posted in this repository. Consult Related URLs below.

Use this Persistent URL to link to this item:


The COVID‐19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10–13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID‐19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID‐19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID‐19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements — notably, in low‐to‐middle income countries — must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens.

Item Type:Article
Related URLs:
URLURL TypeDescription CentralArticle
Fauci, Anthony0000-0002-7865-7235
Günther, Stephan0000-0002-6562-0230
Bente, Dennis A.0000-0002-5150-7368
Yadav, Pragya Dhruv0000-0002-0861-7166
Madoff, Lawrence C.0000-0003-2589-7777
Wang, Lin-Fa0000-0003-2752-0535
Arora, Rahul K.0000-0003-3526-6338
Van Kerkhove, Maria0000-0002-6135-0018
Chu, May C.0000-0002-7896-0496
Jaenisch, Thomas0000-0001-8252-7444
Epstein, Jonathan H.0000-0002-1373-9301
Bausch, Daniel G.0000-0002-7209-6983
Hensley, Lisa E.0000-0003-1188-4342
Bergeron, Éric0000-0003-3398-8628
Sitaras, Ioannis0000-0003-0161-8024
Gunn, Michael D.0000-0003-4602-0667
Geisbert, Thomas W.0000-0003-0858-1877
Muñoz-Fontela, César0000-0002-7725-2586
Krammer, Florian0000-0003-4121-776X
de Wit, Emmie0000-0002-9763-7758
Nordenfelt, Pontus0000-0002-9481-9951
Saphire, Erica Ollmann0000-0002-1206-7451
Corbett, Kizzmekia S.0000-0002-2641-4688
Baize, Sylvain0000-0002-3234-7477
van Doremalen, Neeltje0000-0003-4368-6359
Krieger, Marco A.0000-0003-0030-3952
Costa Clemens, Sue Ann0000-0001-9576-0878
Additional Information:Funding Information: National Institute of Allergy and Infectious Diseases; Canadian Medical Association; Public Health Agency of Canada; Robert Koch Institute; German Federal Ministry of Health COVID-19 Research and Development; WHO Solidarity Response Fund R.K.A. and M.V.K. presented work funded by the WHO Solidarity Response Fund and the German Federal Ministry of Health COVID‐19 Research and Development. R.K.A. would also like to thank the following additional funders of SeroTracker's SARS‐CoV‐2 evidence synthesis efforts: the Public Health Agency of Canada through Canada's COVID‐19 Immunity Task Force, the Robert Koch Institute, and the Canadian Medical Association Joule Innovation Fund. M.V.K. is employed by the WHO; the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policies, or views of WHO. E.d.W. and N.v.D. are supported by the Intramural Research Program of NIAID, NIH.
Funding AgencyGrant Number
National Institute of Allergy and Infectious DiseasesUNSPECIFIED
Canadian Medical AssociationUNSPECIFIED
Public Health Agency of CanadaUNSPECIFIED
Issue or Number:1
PubMed Central ID:PMC9538336
Record Number:CaltechAUTHORS:20221017-15547800.42
Persistent URL:
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:117477
Deposited By: Research Services Depository
Deposited On:21 Oct 2022 01:25
Last Modified:25 Jan 2023 18:56

Repository Staff Only: item control page